Unknown

Dataset Information

0

Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus.


ABSTRACT: Lymphatic endothelial cells (LECs) are differentiated from blood vascular endothelial cells (BECs) during embryogenesis and this physiological cell fate specification is controlled by PROX1, the master regulator for lymphatic development. When Kaposi sarcoma herpes virus (KSHV) infects host cells, it activates the otherwise silenced embryonic endothelial differentiation program and reprograms their cell fates. Interestingly, previous studies demonstrated that KSHV drives BECs to acquire a partial lymphatic phenotype by upregulating PROX1 (forward reprogramming), but stimulates LECs to regain some BEC-signature genes by downregulating PROX1 (reverse reprogramming). Despite the significance of this KSHV-induced bidirectional cell fate reprogramming in KS pathogenesis, its underlying molecular mechanism remains undefined. Here, we report that IL3 receptor alpha (IL3R?) and NOTCH play integral roles in the host cell type-specific regulation of PROX1 by KSHV. In BECs, KSHV upregulates IL3R? and phosphorylates STAT5, which binds and activates the PROX1 promoter. In LECs, however, PROX1 was rather downregulated by KSHV-induced NOTCH signal via HEY1, which binds and represses the PROX1 promoter. Moreover, PROX1 was found to be required to maintain HEY1 expression in LECs, establishing a reciprocal regulation between PROX1 and HEY1. Upon co-activation of IL3R? and NOTCH, PROX1 was upregulated in BECs, but downregulated in LECs. Together, our study provides the molecular mechanism underlying the cell type-specific endothelial fate reprogramming by KSHV.

SUBMITTER: Yoo J 

PROVIDER: S-EPMC3375311 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC2904577 | BioStudies
2012-01-01 | S-EPMC3500425 | BioStudies
2010-01-01 | S-EPMC2807354 | BioStudies
1000-01-01 | S-EPMC1838981 | BioStudies
2018-01-01 | S-EPMC5770555 | BioStudies
2010-01-01 | S-EPMC2921153 | BioStudies
2014-01-01 | S-EPMC3986404 | BioStudies
2013-01-01 | S-EPMC3774835 | BioStudies
1000-01-01 | S-EPMC3447786 | BioStudies
1000-01-01 | S-EPMC5373895 | BioStudies